Publications for Option B Plus

In option B+, side-effects and needing time to think are key reasons for not taking HIV medication

A qualitative study conducted in Malawi on a sample of 65 women of which some rejected  Option B+ and some interrupted their treatment. Option B+ entails HIV treatment for life for HIV infected pregnant women regardless of CD4 count or disease stage. Researchers were interested in the barriers in engaging in care. From the sample, [read more …]

Studies probe retention in HIV care for women who start antiretroviral treatment during pregnancy

A collection of studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2016) looking at the reasons for loss to follow-up among mothers enrolled on ART and interventions to improve retention. When mothers ‘LSTFU’ go elsewhere A study in South Africa raised concerns on inaccurately measuring rates of follow-up as estimates did not [read more …]

Option B+ has enabled Malawi to make significant progress towards 90-90-90

Four years later after the inception of Option B+ Malawi has seen the proportion of women with HIV who are diagnosed increase from 49%  to 80%. Similarly viral suppression  now stands at 48% from 2%. Malawi was the first country to introduce Option B+ for PMTCT in 2011. Since then many other countries have adopted [read more …]

Bidirectional links between HIV and intimate partner violence in pregnancy: implications for prevention of mother to child transmission

A qualitative study to explore the links between IPV and HIV-related health among pregnant women and service providers in Johannesburg, South Africa. Ensuring PMTCT adherence is crucial as more countries move towards Option B+ policy to ensure all HIV + pregnant women are initiated on life-long ART. Many structural drivers including stigma, poverty, transport costs [read more …]